These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24021520)

  • 1. Comparing methods for estimating R0 from the size distribution of subcritical transmission chains.
    Blumberg S; Lloyd-Smith JO
    Epidemics; 2013 Sep; 5(3):131-45. PubMed ID: 24021520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inference of R(0) and transmission heterogeneity from the size distribution of stuttering chains.
    Blumberg S; Lloyd-Smith JO
    PLoS Comput Biol; 2013; 9(5):e1002993. PubMed ID: 23658504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of transmissible diseases after elimination.
    De Serres G; Gay NJ; Farrington CP
    Am J Epidemiol; 2000 Jun; 151(11):1039-48; discussion 1049-52. PubMed ID: 10873127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Has surveillance been adequate to detect endemic measles in the United States?
    Harpaz R; Papania MJ; McCauley MM; Redd SB
    J Infect Dis; 2004 May; 189 Suppl 1():S191-5. PubMed ID: 15106110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the status of measles elimination from reported outbreaks: United States, 1997-1999.
    Gay NJ; De Serres G; Farrington CP; Redd SB; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S36-42. PubMed ID: 15106087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying postelimination trends for the introduction and transmissibility of measles in the United States.
    Blumberg S; Enanoria WT; Lloyd-Smith JO; Lietman TM; Porco TC
    Am J Epidemiol; 2014 Jun; 179(11):1375-82. PubMed ID: 24786800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles surveillance in the United States: an overview.
    Guris D; Harpaz R; Redd SB; Smith NJ; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S177-84. PubMed ID: 15106108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles elimination in Canada.
    King A; Varughese P; De Serres G; Tipples GA; Waters J;
    J Infect Dis; 2004 May; 189 Suppl 1():S236-42. PubMed ID: 15106117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated With Measles Transmission in the United States During the Postelimination Era.
    Gastañaduy PA; Funk S; Lopman BA; Rota PA; Gambhir M; Grenfell B; Paul P
    JAMA Pediatr; 2020 Jan; 174(1):56-62. PubMed ID: 31738391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the transmission dynamics of measles in Japan, 2016.
    Nishiura H; Mizumoto K; Asai Y
    Epidemics; 2017 Sep; 20():67-72. PubMed ID: 28359662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Status of Measles Elimination in the United States, 2001-2014.
    Gastañaduy PA; Paul P; Fiebelkorn AP; Redd SB; Lopman BA; Gambhir M; Wallace GS
    Am J Epidemiol; 2017 Apr; 185(7):562-569. PubMed ID: 28338902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of superspreading on epidemic outbreak size distributions.
    Garske T; Rhodes CJ
    J Theor Biol; 2008 Jul; 253(2):228-37. PubMed ID: 18423673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles exportation from Japan to the United States, 1994 to 2006.
    Takahashi H; Saito H
    J Travel Med; 2008; 15(2):82-6. PubMed ID: 18346240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation and prediction for a mechanistic model of measles transmission using particle filtering and maximum likelihood estimation.
    Eilertson KE; Fricks J; Ferrari MJ
    Stat Med; 2019 Sep; 38(21):4146-4158. PubMed ID: 31290184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The basic reproduction number (R
    Guerra FM; Bolotin S; Lim G; Heffernan J; Deeks SL; Li Y; Crowcroft NS
    Lancet Infect Dis; 2017 Dec; 17(12):e420-e428. PubMed ID: 28757186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles in Italy, July 2009 to September 2010.
    Filia A; Tavilla A; Bella A; Magurano F; Ansaldi F; Chironna M; Nicoletti L; Palù G; Iannazzo S; Declich S; Rota MC
    Euro Surveill; 2011 Jul; 16(29):. PubMed ID: 21801692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.
    MMWR Recomm Rep; 1997 Jun; 46(RR-11):1-20. PubMed ID: 9213745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of measles viruses isolated in the united states between 1989 and 2001: absence of an endemic genotype since 1994.
    Rota PA; Rota JS; Redd SB; Papania MJ; Bellini WJ
    J Infect Dis; 2004 May; 189 Suppl 1():S160-4. PubMed ID: 15106105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining and assessing measles elimination goals.
    Papania MJ; Orenstein WA
    J Infect Dis; 2004 May; 189 Suppl 1():S23-6. PubMed ID: 15106085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating transmission intensity for a measles epidemic in Niamey, Niger: lessons for intervention.
    Grais RF; Ferrari MJ; Dubray C; Bjørnstad ON; Grenfell BT; Djibo A; Fermon F; Guerin PJ
    Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):867-73. PubMed ID: 16540134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.